|
End-of-day quote
Buenos Aires S.E.
30/10/2026
|
5-day change | 1st Jan Change | ||
| 1,305.00 ARS | +0.38% |
|
-3.33% | -33.92% |
| Market Cap | 105B 68.26M 60.94M 55.92M 50.87M 95.37M 6.46B 97.27M 668M 269M 3.41B 256M 251M 10.77B | P/E 2024 |
6.08x | P/E 2025 | 51.6x |
|---|---|---|---|---|---|
| Enterprise Value | 336B 218M 195M 179M 162M 304M 20.63B 311M 2.13B 860M 10.89B 818M 800M 34.39B | EV / Sales 2024 |
3.04x | EV / Sales 2025 | 3.08x |
| Free-Float |
17.54% | Yield 2024 |
1.5% | Yield 2025 | - |
Buenos Aires S.E.ARS
| Markets | Quality | ||
|---|---|---|---|
Buenos Aires S.E.
| RICH | End-of-day quote | |
Buenos Aires S.E.
| RICHD | End-of-day quote |
| 1 day | +0.38% | ||
| 1 week | -3.33% | ||
| 1 month | -6.12% | ||
| 3 months | -15.81% | ||
| 6 months | -20.18% | ||
| Current year | -33.92% |
| 1 week | 1,290 | 1,390 | |
| 1 month | 1,290 | 1,580 | |
| Current year | 1,290 | 2,130 | |
| 1 year | 1,290 | 2,300 | |
| 3 years | 595.5 | 2,300 | |
| 5 years | 215 | 2,300 | |
| 10 years | 24.8 | 2,300 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | - | - | |
| General Counsel | - | 28/04/2025 | |
| Corporate Officer/Principal | - | 28/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | - | |
| Director/Board Member | - | - | |
| Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.38% | -3.33% | -18.18% | +94.78% | 68.52M | ||
| -0.57% | +10.19% | +57.22% | +142.90% | 1,263B | ||
| -1.49% | +1.07% | +44.50% | +79.15% | 658B | ||
| -2.32% | +0.50% | +35.96% | +101.16% | 521B | ||
| -1.54% | +0.18% | +53.06% | +66.79% | 391B | ||
| -0.56% | +5.53% | +79.88% | +44.27% | 369B | ||
| -1.69% | +3.17% | +32.18% | +55.35% | 307B | ||
| -0.72% | +7.83% | +12.10% | +33.76% | 290B | ||
| -0.05% | +4.75% | +57.19% | +74.70% | 252B | ||
| -0.24% | +7.01% | +39.13% | +109.05% | 212B | ||
| Average | -0.88% | +5.19% | +39.30% | +80.19% | 426.2B | |
| Weighted average by Cap. | -1.05% | +6.60% | +48.46% | +92.99% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 91.79B 59.46M 53.08M 48.71M 44.31M 83.08M 5.63B 84.73M 582M 235M 2.97B 223M 218M 9.38B | 127B 82.08M 73.28M 67.25M 61.17M 115M 7.77B 117M 803M 324M 4.1B 308M 301M 12.95B |
| Net income | 23.85B 15.44M 13.79M 12.65M 11.51M 21.58M 1.46B 22.01M 151M 60.92M 772M 57.97M 56.73M 2.44B | 3.09B 2M 1.79M 1.64M 1.49M 2.79M 189M 2.85M 19.57M 7.89M 99.94M 7.51M 7.35M 316M |
| Net Debt | 134B 86.56M 77.28M 70.92M 64.51M 121M 8.2B 123M 847M 341M 4.33B 325M 318M 13.66B | 231B 150M 134M 123M 112M 209M 14.17B 213M 1.46B 590M 7.48B 562M 550M 23.62B |
Employees
620
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | ARS 1,305.00 | +0.38% | 693 |
| 29/10/26 | ARS 1,300.00 | -5.80% | 982 |
| 28/10/26 | ARS 1,380.00 | +6.98% | 784 |
| 27/10/26 | ARS 1,290.00 | -2.27% | 993 |
| 26/10/26 | ARS 1,320.00 | -2.22% | 407 |
- Stock Market
- Stocks
- RICH Stock
Select your edition
All financial news and data tailored to specific country editions

















